| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $77.4M | +227.6% |
| Cost of Revenue | $9.3M | +336.1% |
| R&D Expense | $135.0M | +24.2% |
| SG&A Expense | $117.5M | +27.7% |
| Operating Income | -$184.4M | -2.9% |
| Interest Expense | $13.9M | +167.1% |
| Pre-tax Income | -$184.1M | -1.7% |
| Income Tax | $564K | — |
| Net Income | -$184.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.1M | -52.9% |
| Short-term Investments | $215.8M | +4.9% |
| Accounts Receivable | $14.9M | +138.9% |
| Inventory | $8.6M | +195.6% |
| Current Assets | $308.3M | -13.0% |
| Total Assets | $332.7M | -13.0% |
| Current Liabilities | $55.2M | +38.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$136.2M | +21.5% |
| Capital Expenditures | $47K | -83.3% |
| Investing Cash Flow | -$5.7M | -120.2% |
| Financing Cash Flow | $74.4M | -65.2% |
| Free Cash Flow | -$136.2M | +21.6% |
| -2.0% |
| EPS (Basic) | -$3.20 | +7.8% |
| EPS (Diluted) | -$3.20 | +7.8% |
| Total Liabilities |
| $163.0M |
| +37.9% |
| Stockholders' Equity | $169.8M | -35.8% |